We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Statement updating the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for autumn 2023.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination.
For 2022, the primary aim of the COVID-19 vaccination programme continues to be the prevention of severe disease (hospitalisation and mortality) arising from COVID-19.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for autumn 2023.
Statement setting out the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccines for autumn 2022.
Interim advice from the JCVI on the requirements for a potential COVID-19 booster vaccination programme for winter 2021 to 2022
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the spring 2023 COVID-19 vaccination programme.
The Joint Committee on Vaccination and Immunisation (JCVI) is today advising that children at increased risk of serious coronavirus (COVID-19) disease are offered a vaccine.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40.
Paper prepared by the COVID-19 Clinical Information Network (CO-CIN).
The Joint Committee on Vaccination and Immunisation (JCVI) has advised an additional spring booster dose for the most vulnerable individuals in the population.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued its advice on the AstraZeneca COVID-19 vaccine.
The Joint Committee on Vaccination and Immunisation (JCVI) is today advising that all 16 and 17 year olds receive their first dose of the Pfizer-BioNTech vaccine.
The JCVI has reviewed the evidence on vaccinating children aged 12 to 15 who do not have underlying health conditions that put them at increased risk from severe COVID-19.
Committee recommends COVID-19 vaccine for children with underlying medical conditions.
The JCVI has advised that pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.
The JCVI has advised the government to prioritise people experiencing homelessness, including those sleeping rough, for the coronavirus (COVID-19) vaccine.
General information for British people living abroad about getting a vaccine in the country where they live, with links to guidance from regulatory bodies.
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on the COVID-19 vaccine booster programme.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.